“Pathology in Practice: The Breast HER2 Spectrum” will focus on HER2 testing in breast cancer, highlighting the evolution of guidelines to reflect changing clinical practice needs. Discussion topics include a brief review of current testing guidelines and best practices for HER2 scoring using cases to illustrate challenging pre-analytic variables and staining patterns*.
Dylan V Miller, MD, FCAP
Hannah Wen, MD, PhD
David G. Hicks, MD, FCAP
- Summarize recent clinical advances in breast cancer HER2 expression
- Discuss HER2 testing guidelines implementation in practice while appreciating their continuous evolution
- Build on existing interpretation strategies for HER2 IHC analysis in breast cancer
*This webinar is hosted by the CAP Foundation with generous sponsorship from AstraZeneca and Daiichi-Sankyo.